Viyash Scientifi

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE807F01027
  • NSEID: VIYASH
  • BSEID: 512529
INR
278.20
5.45 (2.0%)
BSENSE

Aug 25, 04:01 PM

BSE+NSE Vol: 60.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Marksans Pharma
Corona Remedies
Viyash Scientifi
Akums Drugs
Sudeep Pharma
P & G Health Ltd
Strides Pharma
Blue Jet Health
Sanofi Consumer
Natco Pharma
Jubilant Pharmo

Why is Viyash Scientific Ltd ?

1
Healthy long term growth as Net Sales has grown by an annual rate of 20.85% and Operating profit at 28.24%
2
With a growth in Net Profit of 115.17%, the company declared Very Positive results in Jun 26
  • The company has declared positive results for the last 10 consecutive quarters
  • PAT(Latest six months) At Rs 117.98 cr has Grown at 178.92%
  • NET SALES(Latest six months) At Rs 1,866.32 cr has Grown at 56.39%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 14.26 times
3
Consistent Returns over the last 3 years
  • Along with generating 59.29% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Viyash Scientifi should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Viyash Scientifi for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Viyash Scientifi
59.29%
1.40
42.23%
Sensex
-4.88%
-0.36
13.50%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
20.85%
EBIT Growth (5y)
28.24%
EBIT to Interest (avg)
2.30
Debt to EBITDA (avg)
9.68
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.37
Tax Ratio
35.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.26%
ROCE (avg)
6.09%
ROE (avg)
4.59%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
50
Industry P/E
37
Price to Book Value
4.13
EV to EBIT
25.97
EV to EBITDA
17.22
EV to Capital Employed
3.91
EV to Sales
3.43
PEG Ratio
1.18
Dividend Yield
NA
ROCE (Latest)
13.36%
ROE (Latest)
7.11%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

29What is working for the Company
PAT(Latest six months)

At Rs 117.98 cr has Grown at 178.92%

NET SALES(Latest six months)

At Rs 1,866.32 cr has Grown at 56.39%

OPERATING PROFIT TO INTEREST(Q)

Highest at 14.26 times

PBT LESS OI(Q)

At Rs 104.10 cr has Grown at 143.51%

DEBT-EQUITY RATIO(HY)

Lowest at 0.17 times

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 269.71 cr

-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 3.27 times

Loading Valuation Snapshot...

Here's what is working for Viyash Scientifi

Operating Profit to Interest - Quarterly
Highest at 14.26 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 104.10 cr has Grown at 143.51%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 65.87 cr has Grown at 101.1%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 946.36 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.17 times and Fallen
each half year in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Profit After Tax (PAT) - Quarterly
Highest at Rs 65.87 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Cash and Cash Equivalents - Half Yearly
Highest at Rs 269.71 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Viyash Scientifi

Debtors Turnover Ratio- Half Yearly
Lowest at 3.27 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio